Expression change of ezrin as a prognostic factor in primary osteosarcoma

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Wang, Yao Fei ^a   Shen, Jing Nan ^a   Xie, Xian Biao ^a   Wang, Jin ^a   Huang, Gang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ezrin; Metastasis; Osteosarcoma; Prognostic factor; Survival

Indexed keywords

CISPLATIN; DOXORUBICIN; EZRIN; IFOSFAMIDE; MESSENGER RNA; METHOTREXATE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CHILD; CLINICAL ARTICLE; EVENT FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TREATMENT RESPONSE; TUMOR BIOPSY;

EID: 84655165004     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9684-z     Document Type: Article

References (30)

1. TA Damron WG Ward A Stewart 2007 Osteosarcoma, chondrosarcoma, and Ewing's sarcoma. National cancer data base report Clin Orthop Relat Res 459 40 47 (Pubitemid 46878192)
2. PA Meyers 1992 Chemotherapy for nonmetastatic osteogenic sarcoma: the memorial sloan-kettering experience J Clin Oncol 10 5 15
3. G Bacci 2006 Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution Cancer 106 1154 1161
4. C Kalifa 1993 Chemotherapy in osteogenic sarcoma: the experience of the pediatric department of the Gustave Roussy institute Cancer Treat Res 62 347 349
5. P Bieling 1996 Tumor size and prognosis in aggressively treated osteosarcoma J Clin Oncol 14 848 858 (Pubitemid 26085530)
6. WF Taylor 1989 Prognostic variables in osteosarcoma: a multi-institutional study J Natl Cancer Inst 81 21 30 (Pubitemid 19020933)
7. JC Clark CR Dass PF Choong 2008 A review of clinical and molecular prognostic factors in osteosarcoma J Cancer Res Clin Oncol 134 281 297 (Pubitemid 351170066)
8. EP Buddingh 2010 Prognostic factors in pulmonary metastasized high-grade osteosarcoma Pediatr Blood Cancer 54 216 221
9. P Mangeat C Roy M Martin 1999 ERM proteins in cell adhesion and membrane dynamics Trends Cell Biol 9 187 192 (Pubitemid 29192986)
10. A Vaheri 1997 The ezrin protein family: membrane-cytoskeleton interactions and disease associations Curr Opin Cell Biol 9 659 666 (Pubitemid 27424922)
11. A Bretscher K Edwards RG Fehon 2002 ERM proteins and merlin: integrators at the cell cortex Nat Rev Mol Cell Biol 3 586 599
12. A Gautreau 1999 Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway Proc Natl Acad Sci USA 96 7300 7305 (Pubitemid 29299656)
13. JW Wang 2009 Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1 Cancer Lett 281 71 81
14. KW Hunter 2004 Ezrin, a key component in tumor metastasis Trends Mol Med 10 201 204 (Pubitemid 38581790)
15. S Ilmonen A Vaheri S Asko-Seljavaara O Carpen 2005 Ezrin in primary cutaneous melanoma Mod Pathol 18 503 510 (Pubitemid 40478113)
16. WH Weng J Ahlen K Astrom WO Lui C Larsson 2005 Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas Clin Cancer Res 11 6198 6204 (Pubitemid 41262948)
17. C Khanna 2004 The membrane cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nat Med 10 182 186 (Pubitemid 38524889)
18. P Picci 1985 Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor Cancer 56 1515 1521 (Pubitemid 15228493)
19. G Bacci 2001 Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol Eur J Cancer 37 2030 2039 (Pubitemid 32938106)
20. SS Bielack 2002 Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols J Clin Oncol 20 627 629
21. JH Sohn 2001 Efficacy of pre- and postoperative chemotherapy in patients with osteosarcoma of the extremities Cancer Res Treat 33 520 526
22. Y Zhang 2006 The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness J Cancer Res Clin Oncol 132 685 697 (Pubitemid 44337929)
23. MS Kim WS Song WH Cho SY Lee DG Jeon 2007 Ezrin expression predicts survival in stage IIB osteosarcomas Clin Orthop Relat Res 459 229 236 (Pubitemid 46878222)
24. S Xu-dong 2009 Expression of ezrin correlates with lung metastasis in Chinese patients with osteosarcoma Clin Invest Med 32 180 188
25. SM Bentzen 1988 Prognostic factors in osteosarcomas. A regression analysis Cancer 62 194 202
26. EI Hauben S Weeden J Pringle EA Van Marck PC Hogendoorn 2002 Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup Eur J Cancer 38 1218 1225 (Pubitemid 34603483)
27. HR Park 2006 Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma Pathol Res Pract 202 509 515
28. AJ Provisor 1997 Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group J Clin Oncol 15 76 84 (Pubitemid 27020560)
29. G Rosen 1982 Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy Cancer 49 1221 1230 (Pubitemid 12187826)
30. S Salas 2007 Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas Virchows Arch 451 999 1007 (Pubitemid 350165255)